CAAS CAPITAL MANAGEMENT LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
CAAS CAPITAL MANAGEMENT LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2021$25,411,000
-57.5%
619,939
-54.8%
0.43%
-34.0%
Q1 2021$59,852,000
-69.3%
1,372,123
-64.8%
0.65%
-65.1%
Q4 2020$194,989,000
+1445.0%
3,895,885
+1198.6%
1.86%
+530.2%
Q3 2020$12,621,000
-13.3%
300,0000.0%0.30%
-38.4%
Q2 2020$14,565,000300,0000.48%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders